![ASCO 2022 Conference Coverage](http://media.vumedi.com/thumbs/channel_logo/2022/5/eadfa937-de35-4504-be38-58654669525f.png.200x0_q85.png)
ASCO 2022 Conference Coverage
Playback speed
10 seconds
ASCO 2022 on Atezolizumab + Bevacizumab vs Lenvatinib or Sorafenib in Non-Viral Unresectable HCC: An International Study
By
ASCO 2022 Conference Coverage
FEATURING
Margherita Rimini
By
ASCO 2022 Conference Coverage
FEATURING
Margherita Rimini
270 views
August 5, 2022
Login to view comments.
Click here to Login
GI